Avoro Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Avoro Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-456,223	Closed	-$28M	–	58
2017 Q4	$28M	Buy	+456,223	New	+$28.5M	1.81%	18
2017 Q1	–	Sell	-285,000	Closed	-$16.7M	–	48
2016 Q4	$16.7M	Sell	285,000 -114,875	-29%	-$6.28M	3.36%	13
2016 Q3	$21.6M	Sell	399,875 -45,464	-10%	-$2.92M	3.78%	11
2016 Q2	$32.8M	Buy	445,339 +270,339	+154%	+$19.1M	7.28%	5
2016 Q1	$11.2M	Buy	+175,000	New	+$11M	3.9%	10

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avoro Capital Advisors's BMY Position: Q1 2018 in Review

Avoro Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 456,223 shares — an estimated $28M sold.

Avoro Capital Advisors first reported a position in BMY in Q1 2016 and held it in 5 quarters. The position peaked at $32.8M in Q2 2016. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

Avoro Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
Avoro Capital Advisors sold 456,223 Bristol-Myers Squibb shares in Q1 2018, an estimated $28M.
Avoro Capital Advisors first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 5 quarters.
Avoro Capital Advisors's Bristol-Myers Squibb position peaked at $32.8M in Q2 2016.
1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Avoro Capital Advisors's 13F filing for Q1 2018, filed 15 May 2018.